Home - Products - Others - Other Targets - 3,3-Tetramethyleneglutarimide

3,3-Tetramethyleneglutarimide

CAS No. 1075-89-4

3,3-Tetramethyleneglutarimide( —— )

Catalog No. M32716 CAS No. 1075-89-4

Compound Fr14035 is a useful organic compound for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,3-Tetramethyleneglutarimide
  • Note
    Research use only, not for human use.
  • Brief Description
    Compound Fr14035 is a useful organic compound for research related to life sciences.
  • Description
    Compound Fr14035 is a useful organic compound for research related to life sciences. The catalog number is Fr14035 and the CAS number is 1075-89-4.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1075-89-4
  • Formula Weight
    167.21
  • Molecular Formula
    C9H13NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1CC2(CCCC2)CC(=O)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • [D-Ala2]-b-Casomorph...

    [D-Ala2]-b-Casomorphin (1-6), bovine

  • Propiconazole

    Propiconazole (Standard) is the analytical standard of Propiconazole. This product is intended for research and analytical applications. Propiconazole is an orally active N-substituted triazole used as a fungicide. Propiconazole is a mouse liver hepatotoxicant and a hepatocarcinogen that has adverse reproductive and developmental toxicities in experimental animals.

  • 2-Hydroxy-3-methylan...

    2-Hydroxy-3-methylanthraquinone enhances apoptosis of U937 cells,in part,through activation of p-p38MAPK and downregulation of p-ERK1/2; triggers caspase-3 activation mediated apoptotic induction.